Use of novel antiretroviral agents in rescue regimens: A case of early virological failure to raltegravir

Chiara Tommasi, Francesca Ceccherini-Silberstein, Roberta D'Arrigo, Rita Bellagamba, Massimo Tempestilli, Carlo Dess, Maria M. Santoro, Federica Forbici, Emanuele Nicastri, Leopoldo P. Pucillo, Carlo F. Perno, Pasquale Narciso

Research output: Contribution to journalArticle

Abstract

In patients with virological failure during highly active antiretroviral therapy (HAART) and drug resistance, guidelines recommend the achievement of maximal virological suppression by the use of a new regimen with at least 2 active drugs. We describe the clinical outcome of a heavily antiretroviral- experienced patient who experienced early failure to raltegravir.

Original languageEnglish
Pages (from-to)237-239
Number of pages3
JournalScandinavian Journal of Infectious Diseases
Volume42
Issue number3
DOIs
Publication statusPublished - 2010

Fingerprint

Anti-Retroviral Agents
Highly Active Antiretroviral Therapy
Drug Resistance
Guidelines
Pharmaceutical Preparations
Raltegravir Potassium

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology and Microbiology(all)
  • Infectious Diseases

Cite this

Use of novel antiretroviral agents in rescue regimens : A case of early virological failure to raltegravir. / Tommasi, Chiara; Ceccherini-Silberstein, Francesca; D'Arrigo, Roberta; Bellagamba, Rita; Tempestilli, Massimo; Dess, Carlo; Santoro, Maria M.; Forbici, Federica; Nicastri, Emanuele; Pucillo, Leopoldo P.; Perno, Carlo F.; Narciso, Pasquale.

In: Scandinavian Journal of Infectious Diseases, Vol. 42, No. 3, 2010, p. 237-239.

Research output: Contribution to journalArticle

Tommasi, Chiara ; Ceccherini-Silberstein, Francesca ; D'Arrigo, Roberta ; Bellagamba, Rita ; Tempestilli, Massimo ; Dess, Carlo ; Santoro, Maria M. ; Forbici, Federica ; Nicastri, Emanuele ; Pucillo, Leopoldo P. ; Perno, Carlo F. ; Narciso, Pasquale. / Use of novel antiretroviral agents in rescue regimens : A case of early virological failure to raltegravir. In: Scandinavian Journal of Infectious Diseases. 2010 ; Vol. 42, No. 3. pp. 237-239.
@article{c477a21dd41b4615a588b5916daec098,
title = "Use of novel antiretroviral agents in rescue regimens: A case of early virological failure to raltegravir",
abstract = "In patients with virological failure during highly active antiretroviral therapy (HAART) and drug resistance, guidelines recommend the achievement of maximal virological suppression by the use of a new regimen with at least 2 active drugs. We describe the clinical outcome of a heavily antiretroviral- experienced patient who experienced early failure to raltegravir.",
author = "Chiara Tommasi and Francesca Ceccherini-Silberstein and Roberta D'Arrigo and Rita Bellagamba and Massimo Tempestilli and Carlo Dess and Santoro, {Maria M.} and Federica Forbici and Emanuele Nicastri and Pucillo, {Leopoldo P.} and Perno, {Carlo F.} and Pasquale Narciso",
year = "2010",
doi = "10.3109/00365540903447018",
language = "English",
volume = "42",
pages = "237--239",
journal = "Scandinavian Journal of Infectious Diseases",
issn = "0036-5548",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Use of novel antiretroviral agents in rescue regimens

T2 - A case of early virological failure to raltegravir

AU - Tommasi, Chiara

AU - Ceccherini-Silberstein, Francesca

AU - D'Arrigo, Roberta

AU - Bellagamba, Rita

AU - Tempestilli, Massimo

AU - Dess, Carlo

AU - Santoro, Maria M.

AU - Forbici, Federica

AU - Nicastri, Emanuele

AU - Pucillo, Leopoldo P.

AU - Perno, Carlo F.

AU - Narciso, Pasquale

PY - 2010

Y1 - 2010

N2 - In patients with virological failure during highly active antiretroviral therapy (HAART) and drug resistance, guidelines recommend the achievement of maximal virological suppression by the use of a new regimen with at least 2 active drugs. We describe the clinical outcome of a heavily antiretroviral- experienced patient who experienced early failure to raltegravir.

AB - In patients with virological failure during highly active antiretroviral therapy (HAART) and drug resistance, guidelines recommend the achievement of maximal virological suppression by the use of a new regimen with at least 2 active drugs. We describe the clinical outcome of a heavily antiretroviral- experienced patient who experienced early failure to raltegravir.

UR - http://www.scopus.com/inward/record.url?scp=76649095670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76649095670&partnerID=8YFLogxK

U2 - 10.3109/00365540903447018

DO - 10.3109/00365540903447018

M3 - Article

C2 - 20085429

AN - SCOPUS:76649095670

VL - 42

SP - 237

EP - 239

JO - Scandinavian Journal of Infectious Diseases

JF - Scandinavian Journal of Infectious Diseases

SN - 0036-5548

IS - 3

ER -